{"task_id": "f112823bc411cd95", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 116/464)", "text": "(initial dose 0.05 0.15 mg/kg up to\nToxicology\n103\n\n--- Page 125 ---\nb BLOCKER OVERDOSE (CONT\u2019D)\na max dose of 10 mg over 2 min, then infusion\n0.07 mg/kg), IV calcium, phosphodiesterase inhi\nbitor (milrinone or amrinone), epinephrine, dialysis\nfor atenolol or sotalol, insulin/glucose infusions,\natropine, or pacing not usually effective\nCALCIUM CHANNEL BLOCKERS OVERDOSE\nCAUSES\ndihydropyridine calcium channel blockers\n(nifedipine, amlodipine, isradipine) affect mainly vas\ncular tone and may cause hypotension with reflex\ntachycardia. Non dihydropyridine calcium channel\nblockers (diltiazem, verapamil) usually lead to SA/AV\nslowing and negative inotropy\nCLINICAL FEATURES\ncommon (hypotension, arrhy\nthmias, delirium, hypokalemia, lactic acidosis, hyper\nglycemia)\nTREATMENTS\nsupportive measures. Fluid resuscita\ntion. IV calcium (calcium gluconate 10% 50 mL or\ncalcium chloride 10% 20 mL). Glucagon. Insulin/glu\ncose infusions\nLITHIUM TOXICITY\nCAUSES\nusually related to chronic drug accumula\ntion, although acute overdose may occur. Common\nrisk factors include renal failure and dehydration.\nTherapeutic Li levels 0.6 1.2 mEq/L, mild toxicity=1.5\nto <2.5 mEq/L, moderate toxicity=2.5 3.5 mEq/L,\nsevere toxicity >3.5 mEq/L\nCLINICAL FEATURES\nacute toxicities include CNS\n(confusion, ataxia, seizures, coma), neuromuscular\n(tremors, fasciculations, rigidity, weakness), and\nothers (sinus bradycardia, hypotension, ARDS, acute\nrenal failure, nausea and vomiting, diarrhea, leukocy\ntosis, hypercalcemia). Chronic toxicities include dia\nbetes insipidus, leukocytosis, and goiter\nTREATMENTS\nsupportive\nmeasures,\ngastric\nlavage if within 60 min of ingestion, hypotonic solu\ntion infusion, Kayexalate (binds lithium), whole\nbowel irrigation, hemodialysis (if Li >3.5 mEq/L in\nacute ingestion or >2.5 mEq/L in chronic ingestion\nAND significant symptoms, or persistently high Li\nlevels, beware of rebound effect after hemodialysis\ndue to redistribution)\nRelated Topics\nABG (p. 77)\nAlcohol Abuse (p. 105)\nDelirium/Coma (p. 380)\nECG (p. 62)\nSeizures (p. 309)\nDIAGNOSTIC ISSUES FOR OVERDOSE\nOSMOLAR GAP\nmeasured osmolality\ncalculated\nosmolality, where Osmocalc wGUN2w\n\u0004 Osmocalc = (Glucose in mmol/L) + (Urea in mmol/L)\n+ 2\u0002(Na mmol/L)\n\u0004 or in US units: Osmocalc = (Glucose in mg/dL)/18 +\n(Urea in mg/dL)/2.8 + 2\u0002(Na mEq/L)\n\u0004\nNORMAL OSMOLAR GAP\ntypically\n2 to +6 mOsm/\nkg\n\u0004\nINCREASED OSMOLAR GAP AND ANION GAP\nethylene\nglycol, methanol, diabetic or alcoholic ketoacido\nsis, lactic acidosis, chronic renal failure (other small\nsolutes), severe lactic acidosis (\u2018\u2018idiogenic osmole\u2019\u2019),\nsevere sepsis (some inflammatory mediators are\nbelieved to be osmotically active)\n\u0004\nINCREASED OSMOLAR GAP BUT NORMAL ANION GAP\nethanol, isopropyl alcohol, diethyl ether, sorbitol,\nmannitol,\nsevere\nhyperproteinemia,\nsevere\nhyperlipidemia\nANION GAP (AG)\nNa\nCl\nHCO3. AG >12 mEq/L is\nabnormal and can be caused by methanol, ethylene\nglycol, uremia, ketoacidosis, paraldehyde, INH, iron,\nlactic acidosis, cyanide, arsenic, toluene, salicylates\n(see METABOLIC ACIDOSIS p. 77). Decreased anion\ngap can be caused by excessive cations such as in Li\ntoxicity. Remember to adjust AG in hypoalbuminemia\nby adding 2.5 3 mmol/L for every 10 g/L [1.0 g/dL]\ndecrease in serum albumin). A \u2018normal\u2019 AG may actu\nally be elevated in the setting of hypoalbuminemia\nOXYGEN\nSATURATION\nGAP\n>5%\ndifference\nbetween pulse oximetry and oxygen saturation on\nABG is seen with carbon monoxide, cyanide, hydro\ngen sulfide, and methemoglobin poisoning\nANTICHOLINERGIC\nAND\nSYMPATHOMIMETIC\nSYNDROMES\nanticholinergic syndromes lead to\ndry skin whereas sympathomimetic syndromes are\nassociated with diaphoresis\nMANAGEMENT OF OVERDOSES\n1. ACUTE\nABC, O2, IV, universal antidote (glucose\n25 50 g IV if capillary glucose measurement not\nimmediately available, naloxone 0.4 2 mg IV, thia\nmine 50 100 mg IV). Supportive care for airway\nprotection (intubation if GCS \b8, severe hypoxe\nmia/hypercapnia and/or hemodynamic instabil\nity), blood pressure (fluids, vasoactive drugs),\narrhythmias, agitation, and seizures\n2. DECONTAMINATION\nactivated charcoal 50 100 g\nPO with 60 mL sorbitol (within 1 hour ingestion of\nmost\ndrugs\nexcept\nthose\nthat\nare\nrapidly\nabsorbed). Avoid if bowel obstruction, perforation,\nor endoscopy is contemplated. Gastric lavage\nwith 2 3 mL/kg aliquots if within 60 min of inges\ntion (should be tried even after 60 min if delayed\ngastric emptying, e.g. TCA overdose) and if\n104\nToxicology", "text_length": 4437, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 116/464)", "type": "chunk", "chunk_index": 115, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.403521", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.404288", "status": "complete", "chunks_added": 3}